As Ozempic, Wegovy, Mounjaro and other injectable diabetes and weight-loss medications continue to make headlines for the successes and challenges many see with the medications for obesity and metabolic conditions, questions — regarding impacts on pregnant persons, potential uses for other medical conditions, concerns over counterfeit products that have flooded the market, discussions over what these mean for those with histories of disordered eating and more — continue to emerge.
On Monday, March 18, 2024, experts from the University of Maryland, Baltimore (UMB) met with members of the press for a virtual press briefing to discuss these topics and more. UMB’s renowned experts from its Schools of Medicine, Pharmacy, and Social Work provided important updates and insights on various aspects of these medications and their impact on patients.This panel discussion includes:• Experts from University of Maryland Baltimore discuss various medications and their effects• Discussion on the limitations of previous weight loss medications and their side effects• Explanation of how GLP-1 agonists work to control blood glucose levels and decrease hunger• Emphasis on the importance of treating obesity as a chronic disease and the benefits of doing so
More from Youtube
- 1:20HRT & Compounded Products: What Patients Should KnowNot all hormone replacement therapies are the same. Compounded products raise unique questions about safety and effectiveness.University of Maryland School of Medicine professor Audra Stinchcomb, PhD, RPh, FAAPS, FAIMBE, explains the latest insights — helping patients and providers make informed choices.This research is supported by the U.S. Food and Drug Administration (FDA).#BreakthroughsCantWait #HormoneTherapy #FDAResearch #UMBresearch #WomensHealth
- 1:46Hormone Replacement Therapy: Risks, Benefits & Compounded ProductsWhat should patients and providers know about hormone replacement therapy (HRT)?Audra Stinchcomb, PhD, RPh, FAAPS, FAIMBE, professor of pharmaceutical sciences at the University of Maryland School of Pharmacy, explains the risks, benefits, and what to consider with compounded hormone products.This research is supported by the U.S. Food and Drug Administration (FDA).Learn more about how UMB researchers are advancing science: https://vist.ly/45nuc#HormoneReplacementTherapy #BreakthroughsCantWaitUMB #UMBresearch #FDAResearch
- 0:34FDA-Supported Menopause Research: Finding Safer Relief | Breakthroughs Can’t WaitMenopause symptoms like hot flashes and fatigue disrupt millions of women’s lives. University of Maryland, Baltimore researchers, supported by the U.S. Food and Drug Administration (FDA), are studying safer and more effective ways to manage symptoms—backed by science, not myths.Because breakthroughs can’t wait.#BreakthroughsCantWaitUMB #MenopauseResearch #WomensHealth #FDAResearch #FDAScience #HealthyAging
- 6:05What if Medicines Delivered Through the Skin Were More Precise?Audra Stinchcomb, PhD, RPh, FAAPS, FAIMBE, is working to ensure drug delivery through the skin is safe and effective, and just the right dose — especially for menopausal medicines.Although transdermal patches help patients maintain consistency with drug therapies, it is critical to ensure patients receive just the right dose often over long periods of time.Learn more at https://www.umaryland.edu/breakthroughs#FDA #BreakthroughsCantWaitUMB #Menopause #transdermalpatch
- 1:28How Global Health Research Protects America | Breakthroughs Can’t WaitCongress invests in global health research for one simple reason: diseases don’t stop at the ocean. By stopping outbreaks where they start, this UMB research protects Americans and strengthens global health security.Supported by the National Institutes of Health Fogarty International Center.#BreakthroughsCantWaitUMB #GlobalHealth #NIH #FogartyInternational #HealthSecurity #ResearchProtectsUs #Congress
- 1:08Building Ethical Research Capacity in The Gambia | Breakthroughs Can’t WaitGlobal health breakthroughs depend on more than science. They rely on ethical research that protects communities. In The Gambia, professionals are being trained in research ethics to ensure studies improve care and safeguard people.Supported by the NIH Fogarty International Center.#BreakthroughsCantWaitUMB #GlobalHealth #NIHResearch #FogartyInternational #TheGambia #ResearchEthics #HealthEquity
